Pancytopenia, in particular lymphopenia is treated with compositions which include an IL-15 superagonist, IL-15, an IL-15 mutant, IL-15:IL-15 receptor alpha (IL-15Rα) complex or combinations thereof. Administration of preferred compositions results in the increase of blood cells, in particular, lymphocytes in subjects in need of such treatment.
展开▼